Foto del docente

Carmela Fimognari

Full Professor

Department for Life Quality Studies

Academic discipline: BIOS-11/A Pharmacology

Head of Department for Life Quality Studies

Publications

Fimognari C.; Lenzi M.; Hrelia P., Apoptosis induction by sulfur-containing compounds in malignant and nonmalignant human cells., «ENVIRONMENTAL AND MOLECULAR MUTAGENESIS», 2009, 50, pp. 171 - 189 [Scientific article]

Lenzi M.; Fimognari C.; Cantelli-Forti G.; Hrelia P., Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mice fibroblasts with p53Ser220 mutation., in: Natural compounds in cancer prevention and treatment, BRATISLAVA, Cancer Research Institute, 2009, pp. 44 - 44 (atti di: Natural compounds in cancer prevention and treatment., Smolenice Castle, Slovakia, October 13-15, 2009) [Abstract]

MENDIETA J.R.; C. FIMOGNARI; G.R. DALEO; P. HRELIA; M.G. GUEVARA, Cytotoxic effect of potato aspartic proteases (StAPs) on Jurkat T cells, «FITOTERAPIA», 2009, 10.1016/j.fitote.2009.10.004, pp. - - - [Scientific article]

FIMOGNARI C.; M. LENZI; G. CANTELLI FORTI; P. HRELIA, Cytotoxicity of Hemidesmus indicus extract is associated with apoptosis by activation of mitochondrial pathway and interruption of cell-cycle progression by modulation of cyclin A2 and P21 in human jurkat T cells., in: Libro degli Abstracts, MILANO, Società Italiana di Farmacologia, 2009, pp. - - - (atti di: 34° Congresso Nazionale della Società Italiana di Farmacologia, Rimini, 14-17 Ottobre 2009) [Abstract]

C. Fimognari, Principi attivi negli alimenti nella modulazione del processo cancerogenetico, «L'INTEGRATORE NUTRIZIONALE», 2009, 12(4), pp. 9 - 17 [Scientific article]

FIMOGNARI C.; P. SESTILI; M. LENZI; G. CANTELLI FORTI; P. HRELIA, Protective effect of creatine against RNA damage., «MUTATION RESEARCH», 2009, 670, pp. 59 - 67 [Scientific article]

LENZI M.; C. FIMOGNARI; G. CANTELLI FORTI; P. HRELIA, Studio del potenziale proapoptotico del sulforafane su un modello ex vivo di leucemia., in: Libro degli Abstracts, MILANO, Società Italiana di Tossicologia, 2009, pp. 209 - 209 (atti di: XV Congresso Nazionale Società Italiana di Tossicologia, Verona, 19-22 Gennaio 2009) [Abstract]

Fimognari C.; Lenzi M.; Hrelia P., Chemoprevention of Cancer by Isothiocyanates and Anthocyanins: Mechanisms of Action and Structure-Activity Relationship, «CURRENT MEDICINAL CHEMISTRY», 2008, 15, pp. 440 - 447 [Scientific article]

Fimognari C.; Lenzi M.; Cantelli-Forti G.; Hrelia P., Induction of differentiation in human promyelocytic cells by the isothiocyanate sulforaphane., «IN VIVO», 2008, 22(3), pp. 317 - 320 [Scientific article]

Fimognari C.; Lenzi M.; Hrelia P., Interaction of the isothiocyanate sulforaphane with drug disposition and metabolism: pharmacological and toxicological implications., «CURRENT DRUG METABOLISM», 2008, 9(7), pp. 668 - 678 [Scientific article]

Fimognari C.; Sestili P.; Lenzi M.; Bucchini A.; Cantelli-Forti G.; Hrelia P., RNA as a new target for toxic and protective agents., «MUTATION RESEARCH. FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS», 2008, 648(1-2), pp. 15 - 22 [Scientific article]

Fimognari C.; Lenzi M.; Sciuscio D.; Cantelli-Forti G.; Hrelia P., Cell-cycle specificity of sulforaphane-mediated apoptosis in Jurkat T-leukemia cells., «IN VIVO», 2007, 21, pp. 377 - 380 [Scientific article]

Fimognari C.; Lenzi M.; Sciuscio D.; Cantelli Forti G.; Hrelia P., Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation., «ANNALS OF THE NEW YORK ACADEMY OF SCIENCES», 2007, 1095, pp. 62 - 69 [Scientific article]

Hrelia, Patrizia; Fimognari, Carmela, Effetti tossici delle tossine degli animali terrestri., in: CASARETT DOULLS, Tossicologia. I fondamenti dell’azione delle sostanze tossiche, ROMA, EMSI, 2007, pp. 977 - 997 [Chapter or essay]

Fimognari C.; Hrelia P., Sulforaphane as a promising molecule for fighting cancer, «MUTATION RESEARCH. REVIEWS IN MUTATION RESEARCH», 2007, 635, pp. 90 - 104 [Scientific article]

Latest news

At the moment no news are available.